StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
109
This year
7
Publishing Date
2024 - 03 - 27
2
2023 - 09 - 13
2
2022 - 12 - 30
2
2022 - 04 - 12
2
2022 - 04 - 11
2
2022 - 02 - 09
1
2022 - 02 - 07
1
2022 - 01 - 31
1
2022 - 01 - 04
2
2021 - 12 - 21
2
2021 - 12 - 08
1
2021 - 11 - 30
1
2021 - 11 - 16
1
2021 - 11 - 08
1
2021 - 10 - 19
1
2021 - 10 - 12
1
2021 - 09 - 21
1
2021 - 09 - 08
1
2021 - 08 - 11
1
2021 - 08 - 02
1
2021 - 07 - 13
1
2021 - 06 - 28
1
2021 - 06 - 07
1
2021 - 06 - 03
1
2021 - 06 - 01
1
2021 - 05 - 24
1
2021 - 05 - 13
1
2021 - 05 - 05
1
2021 - 05 - 03
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 12
1
2021 - 04 - 06
1
2021 - 04 - 05
1
2021 - 03 - 23
1
2021 - 03 - 22
1
2021 - 03 - 19
1
2021 - 03 - 17
1
2021 - 03 - 11
1
2021 - 03 - 08
1
2021 - 03 - 03
1
2021 - 03 - 01
1
2021 - 02 - 26
1
2021 - 02 - 25
1
2021 - 02 - 24
1
2021 - 02 - 18
1
2021 - 02 - 17
1
2021 - 02 - 10
1
2021 - 02 - 08
1
2021 - 02 - 02
1
2021 - 01 - 28
1
2021 - 01 - 27
1
2021 - 01 - 20
1
2021 - 01 - 13
1
2021 - 01 - 11
1
2021 - 01 - 05
1
2020 - 12 - 31
1
2020 - 12 - 23
1
2020 - 12 - 21
1
2020 - 12 - 10
1
Sector
Finance and insurance
1
Health technology
109
Manufacturing
1
N/a
1
Tags
Acne
3
Alliances
3
Alzheimer
7
Alzheimer's
14
Alzheimer's disease
4
Alzheimer’s
9
Application
2
Approval
7
Atopic dermatitis
6
Cancer
29
Ceo
2
Cleared
2
Clinical-trials-phase-ii
2
Collaboration
2
Conference
4
Contract
2
Covid
4
Covid-19
3
Dermatitis
9
Designation
2
Direct
2
Disease
12
Drug
12
Endocannabinoid
2
Events
6
Fda
8
Grant
2
Granted
3
Growth
6
Ht-001
7
Ht-alz
11
International
2
Iot
2
License
2
Lupus
3
Meeting
3
N/a
64
Nasdaq
8
Offering
5
Orphan drug
2
Partnership
2
Patent
2
Pharm-country
19
Phase 1
3
Phase 1b
4
Phase 2b
7
Positive
14
Potential
2
Pre-clinical
7
Preclinical
9
Presentation
4
Product-news
5
Research
11
Results
13
Submission
3
Therapeutics
68
Therapy
4
Treatment
24
Trial
20
Xin
3
Entities
Abbvie inc.
156
Abeona therapeutics inc.
115
Adc therapeutics sa
145
Addex therapeutics ltd
101
Akebia therapeutics, inc.
116
Akero therapeutics, inc.
104
Aldeyra therapeutics, inc.
123
Allogene therapeutics, inc.
177
Alphabet inc.
193
Alterity therapeutics limited
106
Amarin corporation plc
134
Amgen inc.
137
Aquestive therapeutics, inc.
147
Astrazeneca plc
117
Autolus therapeutics plc
104
Axsome therapeutics, inc.
116
Biogen inc.
104
Bioxcel therapeutics, inc.
167
Brainstorm cell therapeutics inc.
131
Bristol-myers squibb company
131
Calliditas therapeutics ab
141
Denali therapeutics inc.
104
Eli lilly and company
283
Fate therapeutics, inc.
255
Fulcrum therapeutics, inc.
134
G1 therapeutics, inc.
136
Gilead sciences, inc.
107
Glaxosmithkline plc
150
Horizon therapeutics public limited company
146
Hoth therapeutics, inc.
109
Intellia therapeutics, inc.
112
Johnson & johnson
521
Karyopharm therapeutics inc.
166
Lineage cell therapeutics, inc.
109
Medicenna therapeutics corp.
108
Morgan stanley
208
Morphosys ag
186
Nektar therapeutics
366
Novartis ag
225
Nurix therapeutics, inc.
147
Oncocyte corporation
178
Onconova therapeutics, inc.
113
Outlook therapeutics, inc.
146
Plus therapeutics, inc.
123
Poseida therapeutics, inc.
110
Ptc therapeutics, inc.
266
Relief therapeutics holding sa
109
Sanofi
705
Sarepta therapeutics, inc.
164
Seres therapeutics, inc.
116
Sorrento therapeutics, inc.
229
Spero therapeutics, inc.
121
Tg therapeutics, inc.
148
Therapeuticsmd, inc.
190
Travere therapeutics inc.
120
United therapeutics corporation
142
Vaxart, inc.
181
Vistagen therapeutics, inc.
116
Vyne therapeutics inc.
172
Y-mabs therapeutics, inc.
178
Symbols
ABBV
1
AMGN
1
BMY
1
BXRX
1
HOTH
109
KALA
1
LGVN
1
NUWE
1
REGN
1
SAVA
1
SILO
1
SILOD
1
SNY
1
SNYNF
1
TAK
1
Exchanges
Nasdaq
109
Nyse
2
Crawled Date
2023 - 09 - 13
2
2022 - 12 - 30
2
2022 - 04 - 12
2
2022 - 04 - 11
2
2022 - 03 - 11
1
2022 - 02 - 09
1
2022 - 02 - 07
1
2022 - 01 - 31
1
2022 - 01 - 04
2
2021 - 12 - 21
2
2021 - 12 - 08
1
2021 - 11 - 30
1
2021 - 11 - 16
1
2021 - 11 - 08
1
2021 - 10 - 19
1
2021 - 10 - 12
1
2021 - 09 - 21
1
2021 - 09 - 08
1
2021 - 08 - 11
1
2021 - 08 - 02
1
2021 - 07 - 13
1
2021 - 06 - 28
1
2021 - 06 - 07
1
2021 - 06 - 03
1
2021 - 06 - 01
1
2021 - 05 - 24
1
2021 - 05 - 13
1
2021 - 05 - 05
1
2021 - 05 - 03
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 12
1
2021 - 04 - 06
1
2021 - 04 - 05
1
2021 - 03 - 23
1
2021 - 03 - 22
1
2021 - 03 - 19
1
2021 - 03 - 17
1
2021 - 03 - 11
1
2021 - 03 - 08
1
2021 - 03 - 03
1
2021 - 03 - 01
1
2021 - 02 - 26
1
2021 - 02 - 25
1
2021 - 02 - 24
1
2021 - 02 - 18
1
2021 - 02 - 17
1
2021 - 02 - 10
1
2021 - 02 - 08
1
2021 - 02 - 02
1
2021 - 01 - 28
1
2021 - 01 - 27
1
2021 - 01 - 20
1
2021 - 01 - 13
1
2021 - 01 - 11
1
2021 - 01 - 05
1
2020 - 12 - 31
1
2020 - 12 - 23
1
2020 - 12 - 21
1
2020 - 12 - 10
1
Crawled Time
00:00
2
02:00
1
04:00
1
12:00
5
12:15
5
12:20
6
13:00
14
13:15
2
13:30
5
13:35
1
14:00
14
14:08
1
14:15
1
14:20
1
14:30
1
14:31
1
15:00
10
15:11
1
15:20
1
15:30
3
16:00
5
16:12
1
17:00
7
18:00
9
19:00
3
19:11
1
20:00
1
20:09
1
21:00
2
22:00
2
23:03
1
Source
ir.hoththerapeutics.com
26
www.biospace.com
45
www.prnewswire.com
38
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
entities :
Hoth therapeutics, inc.
save search
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Published:
2024-03-27
(Crawled : 00:00)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-20.81%
|
O:
5.37%
H:
0.64%
C:
-12.1%
obesity
treatment
wholly
Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
Published:
2024-03-27
(Crawled : 18:00)
- prnewswire.com
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-14.49%
|
O:
1.45%
H:
8.57%
C:
8.57%
million
therapeutics
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
Published:
2024-03-19
(Crawled : 15:30)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
2.61%
|
O:
21.74%
H:
19.29%
C:
-3.57%
disease
pre-clinical
positive
treatment
alzheimer's
therapeutics
ht-alz
study
Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
Published:
2024-02-29
(Crawled : 15:00)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-9.23%
|
O:
-2.31%
H:
4.72%
C:
-3.15%
patent
therapeutics
Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic
Published:
2024-02-26
(Crawled : 15:30)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-8.88%
|
O:
-2.7%
H:
6.35%
C:
1.59%
cancer
key
therapeutics
perform
study
Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024
Published:
2024-02-13
(Crawled : 18:00)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-13.87%
|
O:
-0.73%
H:
5.15%
C:
2.94%
ceo
therapeutics
Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients
Published:
2024-01-18
(Crawled : 00:00)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-8.53%
|
O:
5.43%
H:
13.24%
C:
0.74%
ht-001
fda
approval
treat
trial
therapeutics
Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami
Published:
2023-12-27
(Crawled : 13:30)
- prnewswire.com
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-12.59%
|
O:
16.3%
H:
10.19%
C:
2.55%
ht-001
fda
cleared
cancer
expansion
trial
therapeutics
Hoth Therapeutics Announces it Has Successfully Completed Manufacturing of its Cancer fighting HT-KIT for IND-Enabling Studies
Published:
2023-12-05
(Crawled : 13:30)
- prnewswire.com
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-4.84%
|
O:
0.0%
H:
12.1%
C:
4.84%
cancer
therapeutics
Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth's Cancer Fighting HT-KIT
Published:
2023-11-14
(Crawled : 13:30)
- prnewswire.com
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
4.42%
|
O:
6.19%
H:
3.33%
C:
-6.67%
fda
cancer
meeting
therapeutics
Hoth Therapeutics to Present at NobleCon's 19th Annual Emerging Growth Investor Conference, December 3-5, 2023
Published:
2023-11-10
(Crawled : 13:00)
- prnewswire.com
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
2.61%
|
O:
0.0%
H:
0.0%
C:
-3.47%
therapeutics
growth
Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery
Published:
2023-10-05
(Crawled : 14:30)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-14.49%
|
O:
2.9%
H:
16.2%
C:
-2.11%
drug
initiative
therapeutics
FDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patients
Published:
2023-10-02
(Crawled : 13:00)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-22.38%
|
O:
5.9%
H:
0.0%
C:
-7.45%
fda
cancer
treatment
meeting
grants
therapeutics
Hoth Therapeutics Announces Closing of $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Published:
2023-09-15
(Crawled : 19:00)
- prnewswire.com
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
Email alert
Add to watchlist
nasdaq
direct
offering
therapeutics
Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Published:
2023-09-13
(Crawled : 20:00)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-55.97%
|
O:
16.04%
H:
8.36%
C:
-38.26%
nasdaq
direct
offering
therapeutics
Hoth Therapeutics Announces Positive Results Killing Cancer Cells in Both Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia
Published:
2023-09-13
(Crawled : 13:00)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-55.97%
|
O:
16.04%
H:
8.36%
C:
-38.26%
tumors
positive
cancer
gastrointestinal
leukemia
therapeutics
results
Hoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug (Pre-IND) Submission for HT-KIT, Treatment for Cancer Patients
Published:
2023-09-11
(Crawled : 14:00)
- prnewswire.com
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-52.03%
|
O:
-0.81%
H:
16.39%
C:
11.07%
fda
drug
cancer
treatment
therapeutics
submission
Hoth Therapeutics Announces Positive Final Results from 14-day Phase 1b Clinical Trial of BioLexa
Published:
2023-09-06
(Crawled : 14:00)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-45.62%
|
O:
4.61%
H:
2.2%
C:
0.88%
positive
trial
therapeutics
results
Hoth Therapeutics Announces Positive Preclinical End Point Results of HT-ALZ Treatment for Alzheimer's Disease
Published:
2023-08-09
(Crawled : 17:00)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-47.56%
|
O:
8.89%
H:
2.04%
C:
2.04%
disease
positive
treatment
preclinical
alzheimer's
therapeutics
ht-alz
results
Hoth Therapeutics Announces Major Milestone of First Patient Dosed in Phase 2a Clinical Trial
Published:
2023-07-25
(Crawled : 13:00)
- biospace.com/
HOTH
|
$1.22
3.39%
3.28%
22K
|
Health Technology
|
-54.79%
|
O:
1.15%
H:
2.27%
C:
1.89%
trial
therapeutics
milestone
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.